These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32085893)

  • 1. JAK/STAT signaling controls the fate of CD8
    Zhou M; Guo C; Li X; Huang Y; Li M; Zhang T; Zhao S; Wang S; Zhang H; Yang N
    J Autoimmun; 2020 May; 109():102424. PubMed ID: 32085893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S; Yang N; Zhang L; Huang B; Tan H; Liang Y; Li Y; Yu X
    Lupus; 2010 Sep; 19(10):1171-80. PubMed ID: 20501525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
    Front Immunol; 2021; 12():584414. PubMed ID: 33717066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.
    Deng W; Xu M; Meng Q; Li Z; Qiu X; Yin S; Sun D; Dai C; Liu Y
    Rheumatology (Oxford); 2019 Nov; 58(11):2039-2050. PubMed ID: 31329981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zhen-Wu-Tang ameliorates lupus nephritis by diminishing renal tissue-resident memory CD8
    Liang CL; Wei YY; Chen Y; Luo Y; Qin F; Chen Y; Liu H; Qiu F; Wu J; Yang B; Liu Y; Dai Z
    Biomed Pharmacother; 2024 May; 174():116597. PubMed ID: 38643544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus nephritis in the absence of renal major histocompatibility complex class I and class II molecules.
    Mukherjee R; Zhang Z; Zhong R; Yin ZQ; Roopenian DC; Jevnikar AM
    J Am Soc Nephrol; 1996 Nov; 7(11):2445-52. PubMed ID: 8959638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice.
    Dong J; Wang QX; Zhou CY; Ma XF; Zhang YC
    Lupus; 2007; 16(2):101-9. PubMed ID: 17402366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B; Ye H; You X; Ni H; Chen X; Li L
    Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.
    Sharma J; Collins TD; Roach T; Mishra S; Lam BK; Mohamed ZS; Veal AE; Polk TB; Jones A; Cornaby C; Haider MI; Zeumer-Spataro L; Johnson HM; Morel LM; Larkin J
    Sci Rep; 2021 Mar; 11(1):6354. PubMed ID: 33737712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
    Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
    Menke J; Bork T; Kutska B; Byrne KT; Blanfeld M; Relle M; Kelley VR; Schwarting A
    Kidney Int; 2011 Feb; 79(4):452-63. PubMed ID: 20980973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.